Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2023-09-15 to 2026-12-31
Current total value of award: $26449853
Description: THE PURPOSE OF THIS MODIFICATION IS TO FINALIZE THE NOVATION AGREEMENT VIA THIS MODIFICATION THE UNITED STATES GOVERNMENT RECOGNIZES THAT ALL CONTRACTUAL OBLIGATIONS HAVE BEEN TRANSFERRED FROM VENATORX PHARMACEUTICALS, INC. TO BASILEA PHARMACEUTICA I